0001179110-17-007836.txt : 20170523 0001179110-17-007836.hdr.sgml : 20170523 20170523161629 ACCESSION NUMBER: 0001179110-17-007836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170520 FILED AS OF DATE: 20170523 DATE AS OF CHANGE: 20170523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Witek Theodore J. Jr. CENTRAL INDEX KEY: 0001612452 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 17863917 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER NAME: FORMER CONFORMED NAME: WITEK THEODORE L JR DATE OF NAME CHANGE: 20140702 4 1 edgar.xml FORM 4 - X0306 4 2017-05-20 0 0001080014 Innoviva, Inc. INVA 0001612452 Witek Theodore J. Jr. 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 0 1 0 0 Sr. VP & Chief Scientific Off. Common Stock 2017-05-20 4 F 0 2590 11.86 D 251968 D Common Stock 2017-05-22 4 S 0 7815 12.01 D 244153 D The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards. This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. This sale was effected for tax planning purposes. Includes 776 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2017. /s/ Theodore L. Witek, Jr. 2017-05-23